21.07.2011
- Abbott Laboratories reported Wednesday a profit for the second quarter that surged 50% from last year, boosted largely by a significant tax benefit and sales growth. This was...
30.05.2011
- Doubled-Edged Sword - The emergence of biosimilars has caused very large ripples in the biopharma pond, and has recently been called the most "disruptive technology" of the decade...
10.05.2011
- Belgian chemicals group Solvay reported a 79% jump in first-quarter operating profit, beating estimates thanks to improved demand and price hikes, and forecast higher full-year...
14.04.2011
- Roche is poised to kick off the Big Pharma reporting season with a drop in sales due to weaker demand for top-selling Avastin and flu drug Tamiflu and governments' drive to cut...
07.04.2011
- Belgian chemicals group Solvay said on Thursday it will formally launch its agreed €3.4 billion ($4.9 billion) bid for French group Rhodia on July 4, subject to regulatory...
04.04.2011
- Cash-rich Belgian chemicals group Solvay is betting on emerging markets exposure and specialty chemicals with a €3.4 billion ($4.8 billion) cash bid for French group Rhodia. Monday...
26.01.2011
- Becoming Nimble - It's no secret that Big Pharma is facing some of the biggest changes in the history of the industry. The looming patent cliff is now forcing companies to...
13.01.2011
- Belgian chemicals group Solvay made a bid for Danish food ingredients and enzymes group Danisco but lost in the auction to DuPont, Denmark's Borsen newspaper reported on Wednesday...
